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Introduction
Complex regional pain syndrome (CRPS) is 
a chronic and often disabling condition 
that is seen in many patients seeking pain 
management.  The condition leaves 
patients in excruciating pain that is 
disproportionate to the inciting injury.  In 
addition, patients with this pain disorder 
experience abnormal sensations such as 
cold and heat allodynia, hyperalgesia, 
edema, abnormal sudomotor activity and 
trophic changes (Lee et al., 2015).  CRPS 
disproportionally affects four times as 
many women as men (Alexander, Peterlin, 
Perreault, Grothusen, & Schwartzman, 
2012).  There are two types of CRPS: type 
1, often referred to as reflex sympathetic 
dystrophy (RSD), is not evident of nerve 
damage while type 2 does indicate nerve 
damage.  Figure 1 provided by Marinus et 
al. (2011) depicts the appearance of CRPS 
in the acute state; figure 2 depicts the 
appearance of CRPS in the chronic state.  
The pathophysiology of CRPS remains 
unproven: however, many hypotheses 
exist due to this disorder’s multiple system 
dysfunction and the evidence is continuing 
to progress.  As the pathophysiologic 
mechanisms of CRPS further advance, 
treatment modalities will continue to 
emerge in order for health care providers 
to improve the outcomes for patients 
suffering from CRPS. 
Complex regional pain syndrome, formerly 
known as RSD or causalgia, requires more 
education and knowledge pertaining to 
the disease and the underlying processes 
that are involved.  The completed research 
is presented to educate other medical 
professionals on the pathophysiological 
hypotheses behind CRPS, as well as 
individuals that are subject to this pain 
disorder. 
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Additional Sources
CRPS may be caused spontaneously or by 
an inciting injury that causes an abnormal 
response to tissue injury.  The signs and 
symptoms of this multifactorial disorder 
include:
 severe pain,
 Hyperalgesia
 Hyperesthesia
 atypical sudomotor activity
 swelling of the affected limb
 changes in skin color
 cold and heat allodynia
 motor or tropic changes which may 
involve weakness, tremor, dystonia, 
changes of the hair, skin and nails, 
wasting away of tissue, skin or 
muscle and bone thinning. 
CRPS is a painful disorder that effects more 
than 50,000 new cases every year in the 
United States (Watts & Kremer, 2011).  The 
research continues to progress for this 
disorder as the pathophysiology continues 
to unfold.  Current evidence of multiple 
mechanisms interconnected in the 
pathophysiology of CRPS should provide 
for additional discovery and more targeted 
therapeutic interventions for the future.
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Conclusion
Genetic association does appear to play a role in the pain disorder.  CRPS phenotypes are 
correlated with the human leukocyte antigen (HLA) system when two HLA alleles are present 
at the loci (Watts & Kremer, 2011), associating CRPS with a genetic disposition.
Underlying Pathophysiology
The pathophysiology of CRPS remains elusive, but with multiple hypotheses.  CRPS 
involves interactions between the immune system and nervous system.  CRPS also 
involves both the peripheral and central nervous systems.  The traumas usually identified 
in the etiology of CRPS most likely begin with peripheral nociceptive overstimulation and 
can eventually create and sustain the central sensitization that is indicated by the sensory 
factors of the pain disorder (Hardin et al, 2013).  Marinus et al. (2011) has identified 
three major pathophysiological pathways: abnormal inflammatory mechanisms, 
vasomotor dysfunction and maladaptive neuroplasticity.
Alexander et al. (2012) identified significant changes in the plasma cytokines, chemokines, 
and soluble receptors in individuals with CRPS that contribute to the inflammatory process.  
Cytokines most likely act not only in the affected limb, but also in the spinal cord.  Neurologic 
inflammation is most likely the mechanism of post-junction signaling caused by weak 
inactivation of neuropeptides and increased receptor availability (Marinus et al. 2011).  The 
pro-inflammatory cytokines are liable for the initiation and facilitation of inflammatory and 
neuropathic pain and directly contribute to the extravasation of the limb, edema and 
increased cytokine expression in CRPS.  
Vasomotor changes and hyperalgesia have been associated with sympathetic dysfunction.  In 
CRPS, the affected limb is initially warm due to vasoconstrictor neurons and further 
progresses to become cold and a blue-like color.  The up-regulation of alpha-adrenoreceptors
in cutaneous microvasculature has been identified as the mechanism of hypersensitivity 
(Watts & Kremer, 2011).  Watts and Kremer (2011) report that the vasoconstrictor 
adrenoreceptors produce cool and pale skin and the adrenoreceptors on afferent nociceptive 
fibers cause spontaneous pain.  The result of this process is increased circulating 
catecholamines that exacerbate sympathetically mediated symptoms.  Furthermore, the 
sustained vasoconstriction may be caused by changes in the endothelium that cause a 
decreased ability to release endothelial nitric oxide (Marinus et al., 2011). 
Abnormal Inflammatory Mechanisms
Treatment of CRPS involves a combination 
of modalities for both psychological and 
pain symptoms.  Interventional therapies 
include peripheral nerve blocks, spinal cord 
stimulator, pump implantation, chemical 
and surgical sympathectomy and deep 
brain stimulation.  Pharmacological 
therapies consist of bisphosphonate 
compounds, phentolamine, systemic 
steroids, antidepressants, opioids, 
benzodiazepines and membrane stabilizers 
in order to treat the symptoms of this 
syndrome.
Signs & Symptoms
 Patients with CRPS also present 
with anxiety and depression 
when compared to healthy 
individuals.
 The pain is neuropathic in nature 
and is not limited to certain 
dermatomes (Alexander et al., 
2014). 
 The pain caused by CRPS spreads 
proximally over time and may 
even develop on the opposite 
limb. 
 Patients with longstanding CRPS 
tend to perceive their affected 
limb as larger than in reality and 
report feelings of hostility 
toward the limb, feeling as 
though the limb is a separate 
entity and causing the patient to 
desire amputation of the 
affected limb (Marinus et al. 
2011).
Vasomotor Dysfunction
Maladaptive Neuroplasticity
Maladaptive neuroplasticity could be explained by evidence of structural brain changes.  D. 
Lee et al. (2015) reported that CRPS patients revealed significantly decreased cortical 
thickness in the right dorsolateral prefrontal cortex, implying that CRPS is accompanied by 
cerebral atrophy that may contribute to the pathophysiology.  In addition, Pleger et al. 
(2014) found that CRPS patients have an increase in gray matter density in the dorsomedial 
prefrontal cortex which is involved in coding emotional correlates of pain.  This evidence 
demonstrates that brain structure alterations in patients with CRPS are involved in 
regulating cognitive processes including emotional behavior and pain perception.
The central nervous system (CNS) is affected by CRPS.  Although not completely 
understood, central sensitization may occur from lack of restraint of spinal and trigeminal 
nociceptive neurons or enablement of nociceptive activity by excitatory neurons (Marinus
et al. 2011).  Sensitization of the CNS can cause symptoms such as chronic pain, 
hyperalgesia, allodynia and spreading of pain to nearby non-injured areas. 
Figure 1 Acute CRPS (Marinus et al., 2011)
Figure 2 Chronic CRPS (Marinus et al., 2011)
 Figure 3 below, provided by 
Marinus et al. (2011), 
represents clinical features and 
proposed CRPS 
pathophysiological mechanisms
M1=primary motor cortex. S1=primary somatosensory cortex. 
SMA=supplementary motor cortex. IL=interleukin. TNF=tumor necrosis 
factor. NGF=nerve growth factor. CGRP=calcitonin-gene-related 
peptide. SP=substance P. NO=nitric oxide. ET=endothelin.
